Utah mom sues drug company for injuries from COVID vaccine trial.
EXCLUSIVE: A mother from Utah, Brianne Dressen, found herself in a situation where she felt compelled to take legal action against a pharmaceutical company due to a breached contract related to a COVID-19 vaccine clinical trial.
Dressen, a mother of two, participated in a clinical trial for AstraZeneca in November 2020 and received only one dose of the vaccine before experiencing life-altering consequences.
She explained that she felt like she had “no choice” but to sue the drug company after enduring “three and a half years of silence” regarding her injuries from the trial.
Despite giving AstraZeneca multiple opportunities to fulfill their promises of medical and financial support as outlined in the contract she signed, Dressen felt she had to take legal action to hold them accountable.
Diagnosed with “post-vaccine neuropathy” by the National Institute of Health (NIH), Dressen was offered a meager settlement of around $1,200 for her lifelong injuries, which prompted her to seek justice through the lawsuit.
As the first lawsuit of its kind against AstraZeneca in the U.S. regarding the COVID-19 vaccine trial, Dressen’s case sheds light on the challenges faced by individuals dealing with vaccine-related injuries.
Despite facing over 50 similar claims in Europe, the pharmaceutical company decided to withdraw its COVID-19 vaccine from European markets due to a decline in demand, adding more complexities to the situation.
Expressing empathy for others in similar positions, Dressen acknowledged the emotional toll of the legal battle and the inhumane treatment she and others have experienced at the hands of drug companies.
Detailing how the vaccine injuries have impacted her active lifestyle and love for the outdoors, Dressen highlighted the importance of raising awareness about the consequences individuals face when things go awry in clinical trials.
Her hope is that the lawsuit will not only bring her the justice she seeks but also generate awareness about the need for accountability and support for individuals harmed by pharmaceutical products, not just limited to COVID-19 vaccines.
In conclusion, Dressen emphasized the universal need for assistance and justice for anyone facing adverse effects from vaccines or pharmaceutical products, emphasizing the importance of holding companies accountable for their commitments to those who participate in clinical trials.
